vascular interventional therapy

  • 文章类型: English Abstract
    Objective:To investigate the treatment of internal carotid artery rupture after radiotherapy for nasopharyngeal carcinoma. Methods:The clinical data of 7 patients with internal carotid artery rupture after radiotherapy for nasopharyngeal carcinoma from March 2020 to March 2023 were retrospectively analyzed. Results:Skull base osteonecrosis with infection occurred in 4 cases, and tumor recurrence with infection in 3 cases. DSA showed that internal carotid artery rupture was located in the internal carotid artery petrosal segment in 6 cases, and in the paravicular segment in 1 case. Balloon occlusion test(BOT) was performed in 6 patients, of which 3 passed and 3 failed. Vascular treatment included internal carotid artery embolization(4 cases), false aneurysm embolization 1 case(rebleeding), coated stent 1 case(rebleeding), muscle compression during operation(1 case). Patients with rebleeding received high-flow bypass. Three cases developed cerebral infarction after embolization without severe sequelae after treatment, and no death occurred within 90 days. After bleeding control, all 3 patients with cranial base necrosis received surgical treatment to remove the necrotic bone and tissue flap repair, and 1 patient with recurrence received gamma knife and targeted therapy, 1 patient received immune and surgical therapy, and 1 patient received immune and targeted therapy. Conclusion:Rupture and hemorrhage of internal carotid artery after radiotherapy is related to tumor invasion, tissue injury and local infection after radiotherapy. For those caused by tumor invasion, it is recommended to sacrifice the responsible vessels. For those caused by infection, emergency surgery is recommended and blood vessels preserved. Emergency vascular occlusion remains a life-saving option.
    目的:探讨鼻咽癌放疗后颈内动脉破裂的治疗策略。 方法:回顾性分析2020年3月—2023年3月收治的7例鼻咽癌放疗后颈内动脉破裂出血患者的临床资料。 结果:7例患者中4例发生颅底骨坏死伴感染,3例肿瘤复发伴感染。DSA造影提示6例颈内动脉破裂位于颈内动脉岩骨段,1例位于斜坡旁段。6例患者行球囊闭塞试验(BOT),通过3例,未通过3例。血管治疗方案:颈内动脉长程栓塞4例,假性动脉瘤栓塞1例(再出血),覆膜支架1例(再出血),手术中肌肉压迫1例,再出血的患者行高流量搭桥。栓塞后脑梗死3例,经过治疗无后遗症,90 d内无死亡患者。出血控制后3例颅底坏死感染者均行手术治疗清除坏死骨质,并组织瓣修复,1例复发患者行伽马刀及靶向治疗,1例行免疫及手术治疗,1例免疫及靶向治疗。 结论:鼻咽癌放疗后颈内动脉爆裂与肿瘤侵犯和放疗后的损伤和局部组织感染密切相关。对于肿瘤侵犯导致的,建议牺牲责任血管;对于感染造成的破裂出血,建议保留血管,并尽早手术。紧急血管闭塞仍是挽救生命的选择。.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    巨大股动静脉瘘比较少见,通常通过覆膜支架治疗,线圈栓塞,和开放式手术修复。然而,这些选择可能并不适合所有患者.在这里,我们描述了一例创伤性股动静脉瘘,由于长期缺乏治疗,导致股动静脉系统急剧扩张和相当大的心力衰竭症状。鉴于瘘管复杂的解剖位置和患者的严重心功能不全,手术修复通常是不可行的。因此,在这种情况下,我们采用了一种创新的方法,利用室间隔封堵器装置闭合瘘管。这是用间隔封堵器经导管封闭动静脉瘘的第一份报告。
    Giant femoral arteriovenous fistulas are comparatively uncommon, typically treated through covered stents, coil embolization, and open surgical repair. Nevertheless, these options may not be appropriate for all patients. Herein, we describe a case of traumatic femoral arteriovenous fistulas that led to drastic dilatation of the femoral arteriovenous system and considerable heart failure symptoms due to prolonged lack of treatment. Given the intricate anatomical location of the fistula and the patient\'s severe cardiac dysfunction, surgical repair is often unfeasible. Consequently, we adopted an innovative approach in this case, utilizing a ventricular septal occluder device for fistula closure. This constitutes the first report of an arteriovenous fistula transcatheter closure with a septal occluder.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    UNASSIGNED:本研究探讨了下肢动脉硬化闭塞症(LEASO)患者血清HMGB1水平与术后血管再狭窄的相关性。
    UNASSIGNED:本研究共招募了362名接受血管介入治疗的LEASO患者。采用酶联免疫吸附法检测血清HMGB1水平。采用Logistic回归分析确定血管再狭窄的影响因素。R程序用于创建列线图模型。受试者工作特征(ROC)分析用于确定血清HMGB1和列线图模型对血管再狭窄的预测价值。
    未经批准:在纳入的362名LEASO患者中,术后随访6个月内103例(28.45%)出现再狭窄。再狭窄患者术后HMGB1水平明显高于非再狭窄患者。术后HMGB1水平与术后再狭窄程度呈正相关(r=0.819)。术后HMGB1诊断术后再狭窄的AUC为0.758(95%CI:0.703-0.812),敏感性和特异性分别为56.31%和82.24%,分别。多因素logistic回归分析显示,吸烟,术后常规用药,纤维蛋白原增加,红细胞减少,hs-CRP升高,术后HMGB1升高与LEASO患者术后再狭窄独立相关。根据上述7个影响因素构建的列线图预测模型的C指数为0.918。与单个术后HMGB1相比,列线图模型对LEASO患者术后再狭窄的预测能力更高(AUC:0.918,95%CI:0.757-0.934)。
    UNASSIGNED:术后血清HMGB1是LEASO患者术后血管再狭窄的独立危险因素,基于术后血清HMGB1结合临床特征的新型列线图模型可能有助于准确预测LEASO患者术后再狭窄的风险。
    UNASSIGNED: This study explored the correlation between serum HMGB1 levels and postoperative vascular restenosis in patients with lower extremity arteriosclerosis obliterans (LEASO).
    UNASSIGNED: A total of 362 patients LEASO who received vascular intervention were recruited in this study. Serum HMGB1 levels were measured by enzyme-linked immunosorbent assay. Logistic regression analysis was used to identify the influencing factors associated with vascular restenosis. The R procedure was used to create nomogram model. Receiver operating characteristic (ROC) analysis was used to determine the predictive value of serum HMGB1 and nomogram model for vascular restenosis.
    UNASSIGNED: Of the 362 LEASO patients included, 103 (28.45%) developed restenosis within 6 months of postoperative follow-up. Postoperative HMGB1 levels were significantly higher in patients with restenosis compared to those with non-restenosis. Postoperative HMGB1 levels were significantly and positively correlated with the severity of postoperative restenosis (r = 0.819). The AUC of postoperative HMGB1 for the diagnosis of postoperative restenosis was 0.758 (95% CI: 0.703-0.812), with a sensitivity and specificity of 56.31% and 82.24%, respectively. Multivariate logistic regression analysis showed that diabetes, smoking, regular postoperative medication, increased fibrinogen, decreased red blood cells, increased hs-CRP, and increased postoperative HMGB1 were independently associated with postoperative restenosis in patients with LEASO. The C-index of the nomogram prediction model constructed based on the seven influencing factors mentioned above was 0.918. The nomogram model was significantly more predictive of postoperative restenosis in LEASO patients compared with a single postoperative HMGB1 (AUC: 0.918, 95% CI: 0.757-0.934).
    UNASSIGNED: Postoperative serum HMGB1 is an independent risk factor associated with postoperative vascular restenosis in patients with LEASO, and a novel nomogram model based on postoperative serum HMGB1 combined with clinical characteristics may help to accurately predict the risk of postoperative restenosis in patients with LEASO.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号